A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia

Therapy-related acute lymphoblastic leukemia represents a distinct entity associated with inferior survival compared with de novo acute lymphoblastic leukemia. It consists of a subset of patients who have had exposure to chemotherapy or radiation for a previous malignancy. Here, we describe a case o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shikdar, Sufana, Ying, Yuan, Khawandanah, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904593/
https://www.ncbi.nlm.nih.gov/pubmed/35284228
http://dx.doi.org/10.1016/j.lrr.2022.100297
_version_ 1784664988009365504
author Shikdar, Sufana
Ying, Yuan
Khawandanah, Mohamad
author_facet Shikdar, Sufana
Ying, Yuan
Khawandanah, Mohamad
author_sort Shikdar, Sufana
collection PubMed
description Therapy-related acute lymphoblastic leukemia represents a distinct entity associated with inferior survival compared with de novo acute lymphoblastic leukemia. It consists of a subset of patients who have had exposure to chemotherapy or radiation for a previous malignancy. Here, we describe a case of acute myeloid leukemia who later developed precursor B cell acute lymphoblastic leukemia and discuss the current relevant literature. Our case highlights the importance of classifying therapy-related acute lymphoblastic leukemia as a separate as entity based on its biologic and clinical features.
format Online
Article
Text
id pubmed-8904593
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89045932022-03-10 A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia Shikdar, Sufana Ying, Yuan Khawandanah, Mohamad Leuk Res Rep Article Therapy-related acute lymphoblastic leukemia represents a distinct entity associated with inferior survival compared with de novo acute lymphoblastic leukemia. It consists of a subset of patients who have had exposure to chemotherapy or radiation for a previous malignancy. Here, we describe a case of acute myeloid leukemia who later developed precursor B cell acute lymphoblastic leukemia and discuss the current relevant literature. Our case highlights the importance of classifying therapy-related acute lymphoblastic leukemia as a separate as entity based on its biologic and clinical features. Elsevier 2022-03-01 /pmc/articles/PMC8904593/ /pubmed/35284228 http://dx.doi.org/10.1016/j.lrr.2022.100297 Text en © 2022 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Shikdar, Sufana
Ying, Yuan
Khawandanah, Mohamad
A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
title A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
title_full A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
title_fullStr A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
title_full_unstemmed A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
title_short A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
title_sort case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904593/
https://www.ncbi.nlm.nih.gov/pubmed/35284228
http://dx.doi.org/10.1016/j.lrr.2022.100297
work_keys_str_mv AT shikdarsufana acaseoftherapyrelatedacutelymphoblasticleukemiafollowingthetreatmentofacutemyeloidleukemia
AT yingyuan acaseoftherapyrelatedacutelymphoblasticleukemiafollowingthetreatmentofacutemyeloidleukemia
AT khawandanahmohamad acaseoftherapyrelatedacutelymphoblasticleukemiafollowingthetreatmentofacutemyeloidleukemia
AT shikdarsufana caseoftherapyrelatedacutelymphoblasticleukemiafollowingthetreatmentofacutemyeloidleukemia
AT yingyuan caseoftherapyrelatedacutelymphoblasticleukemiafollowingthetreatmentofacutemyeloidleukemia
AT khawandanahmohamad caseoftherapyrelatedacutelymphoblasticleukemiafollowingthetreatmentofacutemyeloidleukemia

Ejemplares similares